Business news – Page 97

Business
Russian investment vehicle sets sights on innovative drugs

2013-03-27T00:00:00Z

Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
Feature
Changing the rules of extraction

2013-03-26T00:00:00Z

As the price of oil goes up, reserves previously uneconomical to exploit become attractive. Nuala Moran explores the chemical technology being used
Business
Court convicts ex-Aptuit researcher over drug data

2013-03-21T00:00:00Z

Altered liquid chromatography results at Scottish site lead to first successful good lab practice prosecution
Business
AstraZeneca partners with Moderna for $240 million

2013-03-21T00:00:00Z

Pharma company sheds more jobs and backs messenger RNA therapeutics
Business
Global AstraZeneca restructuring will cost 1600 jobs

2013-03-19T00:00:00Z

Firm will focus drug development efforts in three strategic R&D centres in the UK, Sweden and the US
Business
Interpol teams up with pharma

2013-03-18T00:00:00Z

Pharmaceutical crime programme will seek to reduce trade in fake drugs
Business
Dow makes $1.5bn divestiture plans

2013-03-15T00:00:00Z

Liveris in favour of ‘selectively pruning’ further non-core units
Business
Dispute over Arkema finances

2013-03-13T00:00:00Z

French speciality chemical company Arkema accused of misrepresenting business sold to investment firm last year
Opinion
New antibiotics: what's the hold up?

2013-03-06T00:00:00Z

It’s more a research problem, than a commercial one, says Derek Lowe
Business
Alcohol dependence pill approved in EU

2013-03-05T00:00:00Z

Selincro tablets from Lundbeck designed to reduce consumption of alcohol
Business
University to acquire Shell UK R&D site

2013-03-05T00:00:00Z

Site at Thornton will become a science park under the stewardship of the University of Chester
Business
UK considers patent rule change for trials

2013-03-04T00:00:00Z

Government to change law that organisations say makes the country less appealing as a location for clinical trials
Business
Dow rapped for $1bn tax scheme

2013-03-01T00:00:00Z

Judge opines: ‘tax law deals in economic realities, not legal abstractions’
Business
Does chemical regulation boost innovation?

2013-02-28T00:00:00Z

Report suggests that supply of innovation responds to extra demand created by new laws
Business
Talk of a $6.6bn deal for Elan

2013-02-27T00:00:00Z

Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
Business
$595m octreotide deal grabs Roche

2013-02-21T00:00:00Z

Company will get worldwide rights to oral formulation of growth hormone drug
Business
Merck resolves Vytorin case for $688m

2013-02-19T00:00:00Z

Investors say the company knew about Enhance trial failure but withheld information
Business
BMS sells OTC drugs for $482m

2013-02-14T00:00:00Z

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser
Business
Ozone device for food packaging

2013-02-12T00:00:00Z

Device uses plasma to create ozone inside sealed packaging
Business
Biogen buys Tysabri from Elan for $3.25bn

2013-02-08T00:00:00Z

Elan earns huge cash injection for blockbuster drug